Searchable abstracts of presentations at key conferences in endocrinology

ea0056p523 | Endocrine Disruptors | ECE2018

Plasma levels of perfluoroalkyl substances and risk of type II diabetes mellitus: a prospective nested case-control study

Donat-Vargas Carolina , Bergdahl Ingvar A. , Tornevi Andreas , Wennberg Maria , Sommar Johan , Kiviranta Hannu , Rantakokko Panu , Rolandsson Olov , AEkesson Agneta

Background: Perfluoroalkyl Substances (PFAS) have drawn much attention due to environment bioaccumulation potential and their presence worldwide in human blood. Exposure to PFAS is suspected to induce endocrine-disrupting hormonal effects and may be involved in the development of type 2 diabetes (T2D). However, epidemiological evidence is scarce and inconsistent.Objective: We aimed to investigate the association of PFAS plasma levels on the risk of devel...